Market Place
Sourcing Support
Benitec Biopharma Releases Q1 2025 Financial Results & Update
14 Nov 2024 //
GLOBENEWSWIRE
Benitec Biopharma CEO to Attend Guggenheim Healthcare Conference
04 Nov 2024 //
GLOBENEWSWIRE
Benitec Biopharma Announces Updated Investor Webcast Information
14 Oct 2024 //
GLOBENEWSWIRE
Benitec Reports Data From BB-301 In Ph 1b/2a Study at Muscle Society
12 Oct 2024 //
GLOBENEWSWIRE
Benitec Biopharma Releases Full Year 2024 Financial Results
26 Sep 2024 //
GLOBENEWSWIRE
Benitec To Present BB-301 Data At World Muscle Society
18 Sep 2024 //
GLOBENEWSWIRE
Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar
17 Sep 2024 //
GLOBENEWSWIRE
Benitec Reports Durable Improvements In OPMD Subject At 180-Day Timepoint
15 Jul 2024 //
GLOBENEWSWIRE
Benitec Biopharma Appoints Kishen Mehta To Board Of Directors
01 Jul 2024 //
GLOBENEWSWIRE
Benitec Biopharma Releases Q3 2024 Results, Operational Update
13 May 2024 //
GLOBENEWSWIRE
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
01 May 2024 //
GLOBENEWSWIRE
Benitec Announces $40M Oversubscribed Private Placement Financing
18 Apr 2024 //
GLOBENEWSWIRE
Benitec Reports Positive Interim BB-301 OPMD Trial Data
18 Apr 2024 //
GLOBENEWSWIRE
Benitec Biopharma to Discuss BB-301 Program on April 18
09 Apr 2024 //
GLOBENEWSWIRE
Benitec Biopharma Releases Second Quarter 2024 Financial Results
13 Feb 2024 //
GLOBENEWSWIRE
Benitec Announces First Subject Dosed in Phase 1b/2a Clinical Trial for BB-301
30 Nov 2023 //
GLOBENEWSWIRE
Benitec Biopharma to Participate in a Fireside Chat at Conference
17 Nov 2023 //
GLOBENEWSWIRE
Benitec Biopharma Releases First Quarter 2024 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Benitec Releases Full Year 2023 Financial Results & Provides Operational Update
21 Sep 2023 //
GLOBENEWSWIRE
Benitec Biopharma Announces Closing of $30 Million Underwritten Public Offering
11 Aug 2023 //
GLOBENEWSWIRE
Benitec Biopharma Announces Pricing of $30 Million Underwritten Public Offering
08 Aug 2023 //
GLOBENEWSWIRE
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
25 Jul 2023 //
GLOBENEWSWIRE
Benitec Biopharma Receives FDA Clearance of the IND for BB-301
26 Jun 2023 //
GLOBENEWSWIRE
Benitec Biopharma Releases Third Quarter 2023 Financial Results
15 May 2023 //
GLOBENEWSWIRE
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
08 May 2023 //
GLOBENEWSWIRE
Benitec Biopharma to Present at the OPMD International Conference
08 May 2023 //
GLOBENEWSWIRE
Benitec Biopharma Releases Second Quarter 2023 Financial Results
13 Feb 2023 //
GLOBENEWSWIRE
Benitec Biopharma begins OPMD subject enrolment
24 Jan 2023 //
CLINICAL TRIALS ARENA
Benitec Biopharma Enrolls First OPMD Subject into Clinical Development Program
23 Jan 2023 //
GLOBENEWSWIRE
Benitec Biopharma Releases First Quarter 2023 Financial Results
10 Nov 2022 //
GLOBENEWSWIRE
Benitec Biopharma Inc. Announces Closing of $18 Million UPO
16 Sep 2022 //
GLOBENEWSWIRE
Benitec Biopharma Inc. Announces Pricing of $18 Million UPO
12 Sep 2022 //
GLOBENEWSWIRE
Benitec Biopharma Releases Full Year 2022 Financial Results and Provides
02 Sep 2022 //
GLOBENEWSWIRE
Benitec Biopharma Releases Q3 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Benitec Biopharma Discloses Q2 2022 Financial Results
14 Feb 2022 //
PRNEWSWIRE
Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study
08 Sep 2021 //
BIOSPACE
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Trial
08 Sep 2021 //
BIOSPACE
Benitec Biopharma Increases Previously Announced Bought Deal Offering
27 Apr 2021 //
PRNEWSWIRE
Benitec Biopharma Announces Successful Results from the Interim Analysis
24 Feb 2021 //
PRNEWSWIRE
Benitec Biopharma plunges 40% on equity offering
02 Oct 2020 //
SEEKINGALFA
Aduro Biotech, American Renal Associates leads healthcare gainers; Benitec
02 Oct 2020 //
SEEKINGALFA
Benitec reports FY results
23 Sep 2020 //
SEEKING ALPHA
Benitec Begins Early Study of BB-301 Gene Therapy for OPMD
24 Jul 2020 //
MUSCULARDYSTROPHYNEWS
